Glucose Metabolism as a Pre-clinical Biomarker for the Golden Retriever Model of Duchenne Muscular Dystrophy
Sarah M. Schneider(Texas A&M University), Peter P. Nghiem(Texas A&M University), Stanislav Vitha(Texas A&M University), Alan C. Glowcwski(Texas A&M University), Joe N. Kornegay(Texas A&M University), Amanda K. Bettis(Texas A&M University), Scott Jaques(Texas A&M University), Lee‐Jae Guo(Texas A&M University), Rachel Johnson(Texas A&M University), Heather Heath-Barnett(University of North Carolina at Chapel Hill), Vidya Sridhar(Texas A&M University), Cynthia Balog-Alvarez(Texas A&M University)
Cited by 27
Related Papers
Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies
|Mammalian Genome|2012|178
Transient MPK6 activation in response to oxygen deprivation and reoxygenation is mediated by mitochondria and aids seedling survival in Arabidopsis
|Plant Molecular Biology|2011|146
Magnetic Resonance Imaging in Dogs with Neurologic Impairment Due to Acute Thoracic and Lumbar Intervertebral Disk Herniation
|Journal of Veterinary Internal Medicine|2009|118
The Paradox of Muscle Hypertrophy in Muscular Dystrophy
|Physical Medicine and Rehabilitation Clinics of North America|2012|111
Non-immunogenic utrophin gene therapy for the treatment of muscular dystrophy animal models
|Nature Medicine|2019|94